Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
5051
DELISTED
MAG Silver
MAG
| $2.61M | ﹤0.01% |
192,232
+40,551
| +27% | +$630K |
|
5052
PUT
FS KKR Capital
FSK
$3.42B
| $2.61M | ﹤0.01% |
120,200
-56,400
| -32% | -$1.18M |
|
5053
Miller Industries
MLR
$645M
| $2.61M | ﹤0.01% |
39,934
-25,370
| -39% | -$1.73M |
|
5054
Extreme Networks
EXTR
$3.2B
| $2.61M | ﹤0.01% |
155,791
-44,519
| -22% | -$720K |
|
5055
PUT
Biohaven
BHVN
$2.21B
| $2.61M | ﹤0.01% |
69,800
+19,500
| +39% | +$910K |
|
5056
PUT
Guardant Health
GH
$21.1B
| $2.61M | ﹤0.01% |
85,300
-48,400
| -36% | -$1.36M |
|
5057
Vitesse Energy
VTS
$683M
| $2.61M | ﹤0.01% |
104,213
+58,041
| +126% | +$1.52M |
|
5058
PUT
Altimmune
ALT
$572M
| $2.6M | ﹤0.01% |
360,800
+144,800
| +67% | +$1.11M |
|
|
NOVA
5059
CALL
DELISTED
Sunnova Energy
NOVA
| $2.6M | ﹤0.01% |
758,300
-133,100
| -15% | -$666K |
|
5060
Sanmina
SANM
$11.3B
| $2.6M | ﹤0.01% |
34,366
-14,775
| -30% | -$1.1M |
|
5061
Genworth Financial
GNW
$3.84B
| $2.6M | ﹤0.01% |
371,997
+214,156
| +136% | +$1.54M |
|
5062
VEON
VEON
$3.93B
| $2.6M | ﹤0.01% |
64,836
+4,570
| +8% | +$152K |
|
5063
Employers Holdings
EIG
$875M
| $2.59M | ﹤0.01% |
50,639
+24,949
| +97% | +$1.27M |
|
|
SUM
5064
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.59M | ﹤0.01% |
51,174
-800,444
| -94% | -$37.4M |
|
5065
NEOS S&P 500 High Income ETF
SPYI
$11.5B
| $2.59M | ﹤0.01% |
50,948
+16,460
| +48% | +$852K |
|
5066
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.14B
| $2.59M | ﹤0.01% |
+22,255
| New | +$2.71M |
|
5067
Anavex Life Sciences
AVXL
$298M
| $2.59M | ﹤0.01% |
240,906
+215,381
| +844% | +$1.66M |
|
|
FOVL
5068
DELISTED
iShares Focused Value Factor ETF
FOVL
| $2.59M | ﹤0.01% |
36,974
-3,459
| -9% | -$246K |
|
5069
CALL
ATI
ATI
$31.1B
| $2.59M | ﹤0.01% |
47,000
-71,400
| -60% | -$4.21M |
|
|
EH
5070
CALL
EHang Holdings
EH
$450M
| $2.58M | ﹤0.01% |
164,100
-58,900
| -26% | -$946K |
|
|
AZEK
5071
CALL
DELISTED
The AZEK Co
AZEK
| $2.58M | ﹤0.01% |
54,400
-79,700
| -59% | -$3.81M |
|
5072
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $2.58M | ﹤0.01% |
32,660
+18,919
| +138% | +$1.55M |
|
5073
iShares Core S&P US Value ETF
IUSV
$28B
| $2.58M | ﹤0.01% |
27,874
+12,657
| +83% | +$1.22M |
|
5074
CALL
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.3B
| $2.58M | ﹤0.01% |
73,700
+56,400
| +326% | +$2.24M |
|
5075
CALL
Alphatec Holdings
ATEC
$1.51B
| $2.58M | ﹤0.01% |
280,900
+219,400
| +357% | +$1.75M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.